Latest News
Featured News
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell founder says the company is ready to commercialise novel medicines to counteract cancer
Scancell Signs Agreement with Major International Biotechnology Company to Evaluate an Antibody in the Glymab® Portfolio
Scancell receives MHRA approval to expand ModiFY trial
Scancell to present at the 2024 ASCO Annual Meeting
Scancell to present at the Sachs 10th Annual Oncology Innovation Forum
Issue of share options
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.